OTCMKTS:CWBHF

Charlotte's Web Competitors

$3.90
-0.11 (-2.69 %)
(As of 04/20/2021 05:19 PM ET)
Add
Compare
Today's Range
$3.85
Now: $3.90
$4.05
50-Day Range
$4.06
MA: $4.62
$5.21
52-Week Range
$2.10
Now: $3.90
$7.38
Volume389,935 shs
Average Volume548,883 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Charlotte's Web (OTCMKTS:CWBHF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying CWBHF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Charlotte's Web, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Abacus Health Products and Charlotte's Web, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Charlotte's Web01302.75

Charlotte's Web has a consensus price target of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher possible upside, analysts clearly believe Charlotte's Web is more favorable than Abacus Health Products.

Profitability

This table compares Abacus Health Products and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
Charlotte's WebN/AN/AN/A

Earnings & Valuation

This table compares Abacus Health Products and Charlotte's Web's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Summary

Charlotte's Web beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Acreage (OTCMKTS:ACRGF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Earnings & Valuation

This table compares Acreage and Charlotte's Web's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Profitability

This table compares Acreage and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Charlotte's WebN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and recommmendations for Acreage and Charlotte's Web, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Charlotte's Web01302.75

Acreage currently has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Charlotte's Web has a consensus price target of $7.25, indicating a potential upside of 85.76%. Given Acreage's higher possible upside, research analysts clearly believe Acreage is more favorable than Charlotte's Web.

Summary

Charlotte's Web beats Acreage on 2 of the 3 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Applied Biosciences and Charlotte's Web's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Profitability

This table compares Applied Biosciences and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Charlotte's WebN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Applied Biosciences and Charlotte's Web, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Charlotte's Web01302.75

Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Applied Biosciences.

Summary

Charlotte's Web beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Ayr Strategies (OTCMKTS:AYRSF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Ayr Strategies and Charlotte's Web's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Profitability

This table compares Ayr Strategies and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
Charlotte's WebN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Ayr Strategies and Charlotte's Web, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
Charlotte's Web01302.75

Ayr Strategies presently has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Ayr Strategies.

Summary

Ayr Strategies beats Charlotte's Web on 2 of the 3 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Can B and Charlotte's Web's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Profitability

This table compares Can B and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
Charlotte's WebN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Can B and Charlotte's Web, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Charlotte's Web01302.75

Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Can B.

Summary

Charlotte's Web beats Can B on 2 of the 2 factors compared between the two stocks.

Cansortium (OTCMKTS:CNTMF) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent recommendations for Cansortium and Charlotte's Web, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Charlotte's Web01302.75

Cansortium presently has a consensus target price of $1.20, indicating a potential upside of 6.10%. Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher probable upside, analysts clearly believe Charlotte's Web is more favorable than Cansortium.

Valuation and Earnings

This table compares Cansortium and Charlotte's Web's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Profitability

This table compares Cansortium and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
Charlotte's WebN/AN/AN/A

Summary

Charlotte's Web beats Cansortium on 2 of the 3 factors compared between the two stocks.


Charlotte's Web Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00News Coverage
Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.21-81.0%$0.00N/A0.00Increase in Short Interest
Gap Up
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.52-3.5%$0.00N/A0.00Gap Down
Cansortium logo
CNTMF
Cansortium
0.9$1.13-4.5%$0.00N/A0.00Gap Down
Choom logo
CHOOF
Choom
0.5$0.09-2.3%$0.00N/A0.00Gap Down
CPHRF
Cipher Pharmaceuticals
1.2$1.07-0.9%$0.00N/A0.00
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.20-15.0%$0.00N/A0.00News Coverage
Gap Up
Cosmos logo
COSM
Cosmos
0.5$6.30-8.7%$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Down
Cresco Labs logo
CRLBF
Cresco Labs
1.3$11.25-6.5%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$12.77-2.5%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-33.3%$0.00N/A0.00Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-1.7%$0.00N/A0.00
EVIO logo
EVIO
EVIO
0.6$0.00-8.7%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.19-13.5%$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-0.0%$0.00N/A0.00Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-11.3%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$26.82-1.2%$0.00N/A0.00Gap Down
GTEC logo
GGTTF
GTEC
0.6$0.57-6.3%$0.00N/A0.00Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.85-0.7%$0.00N/A0.00Gap Up
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-0.0%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$65.83-5.2%$0.00N/A0.00Gap Down
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.18-6.7%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.27-3.7%$0.00N/A0.00Gap Up
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-0.0%$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.06-0.2%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.38-10.2%$0.00N/A0.00Gap Up
KHTRF
Knight Therapeutics
1.2$4.15-0.7%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-1.0%$0.00N/A0.00News Coverage
Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.37-1.4%$0.00N/A0.00Increase in Short Interest
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.26-7.7%$0.00N/A0.00Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.05-1.3%$0.00N/A0.00Increase in Short Interest
MJardin Group logo
MJARF
MJardin Group
1.1$0.06-16.8%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.02-17.0%$0.00N/A0.00Gap Up
PHCEF
Pharmacielo
0.7$1.34-6.7%$0.00N/A0.00Gap Up
Plus Products logo
PLPRF
Plus Products
1.1$0.51-2.0%$0.00N/A0.00Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-4.0%$0.00N/A0.00Gap Up
PCYN
Procyon
0.4$0.60-0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-2.8%$0.00N/A0.00
SANP
Santo Mining
0.5$0.00-16.3%$0.00N/A0.00
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$12.76-2.1%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-0.0%$0.00N/A0.00News Coverage
TerrAscend logo
TRSSF
TerrAscend
1.7$9.95-1.9%$0.00N/A0.00
The Flowr logo
FLWPF
The Flowr
1.5$0.22-2.5%$0.00N/A0.00Gap Up
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.2$0.28-7.2%$0.00N/A0.00
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.